The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
INDIRECT ALLORECOGNITION OF MAJOR HISTOCOMPATIBILITY COMPLEX ALLOPEPTIDES IN HUMAN RENAL TRANSPLANT RECIPIENTS WITH CHRONIC GRAFT DYSFUNCTION1
Abstract
BACKGROUND: It has been suggested that T cells primed by processed donor major histocompatibility complex antigen (the "indirect" pathway of allorecognition) may be responsible for mediating chronic allograft rejection. The purpose of this study was to develop a clinically useful assay to study the occurrence of indirect allorecognition during chronic rejection in humans. METHODS: A panel of 20 mer peptides corresponding to the hypervariable regions of HLA-DRB1*0101, DRB1*1501, and DRB1*0301 were synthesized. Lymphocytes obtained from renal allograft recipients were cocultured with these peptides. Proliferation was assayed by DNA incorporation of [3H]thymidine, and positive proliferation was defined by a statistically significant increase in counts per minute over background with a minimum stimulation index of 2. The precursor frequency of allopeptide reactive T cells was determined by limiting dilution analysis. RESULTS: Lymphocytes from 82% of patients who were mismatched for at least one of the three DR molecules and had chronic allograft dysfunction specifically proliferated to the mismatched allopeptides (n=11). Proliferation was seen in only 6% of control subjects (2/33, P<0.0001). The proliferative response was low grade and was best detected on day 7-8 of culture in vitro. The precursor frequency of peptide-specific T cells was more than 10-fold higher compared with controls (P<0.001). CONCLUSIONS: These data demonstrate for the first time that T cells of patients with chronic graft dysfunction are primed to recognize and respond to specific donor-derived major histocompatibility complex allopeptides. Our results support the hypothesis that T cells primed via the indirect pathway of allorecognition may be important mediators of chronic rejection and provide the rationale to develop specific therapeutic strategies to prevent or interrupt this process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oates, J. A., Wood, A. J. J., & Kahan, B. D. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912213212507 · Cited by 1,359
Mach, F., Schönbeck, U., Sukhova, G. K., Bourcier, T., Bonnefoy, J.-Y., Pober, J. S., & Libby, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1931 · Cited by 732
LRISK FACTORS FOR CHRONIC REJECTION IN RENAL ALLOGRAFT RECIPIENTS
ALMOND, P. S., MATAS, A., GILLINGHAM, K., DUNN, D. L., PAYNE, W. D., NAJARIAN, J. S., PAUL, G., & RAINER, G. (1993) · Transplantation · doi:10.1097/00007890-199304000-00013 · Cited by 660
Fukaura, H., Kent, S. C., Pietrusewicz, M. J., Khoury, S. J., Weiner, H. L., & Hafler, D. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118779 · Cited by 473
THE IMPACT OF AN ACUTE REJECTION EPISODE ON LONG-TERM RENAL ALLOGRAFT SURVIVAL (t1/2)1,2
MATAS, A. J., GILLINGHAM, K. J., PAYNE, W. D., & NAJARIAN, J. S. (1994) · Transplantation · doi:10.1097/00007890-199403270-00015 · Cited by 435
Hancock, W. W., Sayegh, M. H., Zheng, X.-G., Peach, R., Linsley, P. S., & Turka, L. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13967 · Cited by 411
Self-citationExpression of functional CD40 by vascular endothelial cells.
Hollenbaugh, D., Mischel-Petty, N., Edwards, C. P., Simon, J. C., Denfeld, R. W., Kiener, P. A., & Aruffo, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.33 · Cited by 411
The Molecular Basis of Allorecognition
Sherman, L. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.385 · Cited by 403
Indirect presentation of MHC antigens in transplantation
Shoskes, D. A., & Wood, K. J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90023-x · Cited by 346
Auchincloss, H., Lee, R., Shea, S., Markowitz, J. S., Grusby, M. J., & Glimcher, L. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3373 · Cited by 325
Cited by
The Role of T-Cell Costimulatory Activation Pathways in Transplant Rejection
Sayegh, M. H., & Turka, L. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806183382506 · Cited by 577
Self-citationRethinking Chronic Allograft Nephropathy: The Concept of Accelerated Senescence
HALLORAN, P. F., MELK, A., & BARTH, C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v101167 · Cited by 452
Immunosuppressive strategies in transplantation
Denton, M. D., Magee, C. C., & Sayegh, M. H. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07493-5 · Cited by 449
Self-citationTransplantation 50 Years Later — Progress, Challenges, and Promises
Sayegh, M. H., & Carpenter, C. B. (2004) · New England Journal of Medicine · doi:10.1056/nejmon043418 · Cited by 425
Self-citationRegele, H., Böhmig, G. A., Habicht, A., Gollowitzer, D., Schillinger, M., Rockenschaub, S., Watschinger, B., Kerjaschki, D., & Exner, M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000025780.03790.0f · Cited by 423
Metadata
- Authors
- Vella, J. P., Spadafora-Ferreira, M., Murphy, B., Alexander, S. I., Harmon, W., Carpenter, C. B., & Sayegh, M. H.
- Venue
- Transplantation
- Published
- 1997-09
- Volume
- 64
- Issue
- 6
- Pages
- 795-800
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2043763796
- Cited by
- 293
- References
- 19
- FWCI
- 14.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: INDIRECT ALLORECOGNITION OF MAJOR HISTOCOMPATIBILITY COMPLEX ALLOPEPTIDES IN HUMAN RENAL TRANSPLANT RECIPIENTS WITH CHRONIC GRAFT DYSFUNCTION1. https://app.cochat.ai/papers/10.1097/00007890-199709270-00001
- The paper
- Vella, J. P., Spadafora-Ferreira, M., Murphy, B., Alexander, S. I., Harmon, W., Carpenter, C. B., & Sayegh, M. H. (1997). INDIRECT ALLORECOGNITION OF MAJOR HISTOCOMPATIBILITY COMPLEX ALLOPEPTIDES IN HUMAN RENAL TRANSPLANT RECIPIENTS WITH CHRONIC GRAFT DYSFUNCTION1. Transplantation. https://doi.org/10.1097/00007890-199709270-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.